Rory B Riggs has bought stock on 2 days since Jun 2023

Rory B. Riggs is a seasoned biotechnology executive and investor serving as a Director at Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) since January 8, 2014.( He recently executed stock transactions in June 2024, exercising options for 20,000 shares and selling 4,462 shares, resulting in direct ownership of 116,600 shares.(

Riggs has co-founded numerous biotech companies, including Royalty Pharma (NASDAQ: RPRX), FibroGen (NASDAQ: FGEN), Sugen (NASDAQ: SUGN), and Cibus, where he serves as Chairman.( His career highlights include serving as President and Director of Biomatrix, Inc. (NYSE: BXM) from 1996 to 2000, leading the development and launch of Synvisc® for osteoarthritis treatment,( and earlier roles as Managing Director in Mergers & Acquisitions at PaineWebber Incorporated and Acting President/CEO of RF&P Corporation.( He holds a B.A. from Middlebury College and an MBA from Columbia University.(

Written by Perplexity from public sources.